Year: 2013

Valuing Rare Disease Medicines – We Can Do Better

London, United Kingdom – Many rare diseases, often severe and life-threatening, cannot be treated. The small numbers of patients affected make it time-consuming and costly to compile evidence about treatments. Organisations that pay for health care recognise that a special approach

Posted in Brief Report, Value in Health Tagged with: , , , ,

Payers And Regulators Raise The Bar In Europe

Solna, Sweden – European economies are slowly recovering from economic crises and a number of austerity measures undertaken throughout the last five years. At the same time, payers and regulators within the health care sector are increasing their requirements in order

Posted in ISPOR CONNECTIONS, Outcomes Assessment, Value & Outcomes Spotlight Tagged with: , , ,

Communist Era Beliefs Are Constraining Privatisation Of Health In Poland

Brisbane, Australia – Research by the Chief Executive Officer of the Wesley Research Institute, Professor Christian Gericke, and a team of Polish academics led by Dr. Krzysztof Kaczmarek has found that while privatised health services are perceived in Poland to be

Posted in Value in Health Regional Issues Tagged with: , , ,

What is the Cost of Diarrheal Illness?

Warsaw, Poland – In developed countries acute gastrointestinal infections are common but do not usually cause serious complications. Symptoms such as diarrhea, vomiting and/or abdominal pain, usually last only a few days and as a result, affected people rarely visit their

Posted in Value in Health Regional Issues Tagged with: ,

What is the Role of ISPOR Regional Chapters in Health Technology Implementation?

Budapest, Hungary – Middle income countries often do not have a clear roadmap for the implementation of health technology assessment (HTA) in policy decisions. Since examples from high income countries may not be relevant, roadmaps for the implementation of HTA from

Posted in Value in Health Regional Issues Tagged with: , ,

Curbing Drug Costs: Should Hungary Become A Role Model?

Ljubljana, Slovenia – Trying to control spending on prescription drugs is difficult because the many reasons for pharmaceutical expenditure growth are usually addressed only partially with national prescription drug policies.

Posted in Value in Health Regional Issues Tagged with: , ,

Electronic Referrals In Greece: When Common Sense Becomes Innovation

Athens, Greece –The adoption of e-health systems in Greece is happening at an exceptionally slow pace. Hand-written referral notes were the sole tool available to physicians to order diagnostic exams for their patients, on the basis of which payers reimbursed diagnostic

Posted in Value in Health Regional Issues Tagged with: ,